These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
116 related items for PubMed ID: 7882299
1. Further evidence for promoter-dependent development of hepatoblastoma in the mouse. Diwan BA, Henneman JR, Rice JM. Cancer Lett; 1995 Feb 10; 89(1):29-35. PubMed ID: 7882299 [Abstract] [Full Text] [Related]
2. Dissimilar frequency of hepatoblastomas and hepatic cystadenomas and adenocarcinomas arising in hepatocellular neoplasms of D2B6F1 mice initiated with N-nitrosodiethylamine and subsequently given Aroclor-1254, dichlorodiphenyltrichloroethane, or phenobarbital. Diwan BA, Ward JM, Kurata Y, Rice JM. Toxicol Pathol; 1994 Feb 10; 22(4):430-9. PubMed ID: 7817132 [Abstract] [Full Text] [Related]
3. Promotion of malignant 'embryonal' liver tumors by phenobarbital: increased incidence and shortened latency of hepatoblastomas in (DBA/2 x C57BL/6)F1 mice initiated with N-nitrosodiethylamine. Diwan BA, Ward JM, Rice JM. Carcinogenesis; 1989 Jul 10; 10(7):1345-8. PubMed ID: 2472233 [Abstract] [Full Text] [Related]
4. Enhancement of thyroid and hepatocarcinogenesis by 1,4-bis[2-(3,5- dichloropyridyloxy)]benzene in rats at doses that cause maximal induction of CYP2B. Diwan BA, Henneman JR, Rice JM, Nims RW. Carcinogenesis; 1996 Jan 10; 17(1):37-43. PubMed ID: 8565134 [Abstract] [Full Text] [Related]
5. Tumor promotion by an anticonvulsant agent, phenytoin, in mouse liver: correlation with CYP2B induction. Diwan BA, Henneman JR, Nims RW, Rice JM. Carcinogenesis; 1993 Nov 10; 14(11):2227-31. PubMed ID: 8242847 [Abstract] [Full Text] [Related]
6. Rapid development of hepatic tumors in transforming growth factor alpha transgenic mice associated with increased cell proliferation in precancerous hepatocellular lesions initiated by N-nitrosodiethylamine and promoted by phenobarbital. Tamano S, Merlino GT, Ward JM. Carcinogenesis; 1994 Sep 10; 15(9):1791-8. PubMed ID: 7923571 [Abstract] [Full Text] [Related]
7. Interstrain differences in susceptibility to liver carcinogenesis initiated by N-nitrosodiethylamine and its promotion by phenobarbital in C57BL/6NCr, C3H/HeNCrMTV- and DBA/2NCr mice. Diwan BA, Rice JM, Ohshima M, Ward JM. Carcinogenesis; 1986 Feb 10; 7(2):215-20. PubMed ID: 3948311 [Abstract] [Full Text] [Related]
8. Promotion of hepatocellular foci and adenomas by di(2-ethylhexyl) phthalate and phenobarbital in C3H/HeNCr mice following exposure to N-nitrosodiethylamine at 15 days of age. Weghorst CM, Devor DE, Henneman JR, Ward JM. Exp Toxicol Pathol; 1994 Feb 10; 45(7):423-31. PubMed ID: 8167465 [Abstract] [Full Text] [Related]
9. Genetic susceptibility to murine hepatocarcinogenesis is associated with high growth rate of NDEA-initiated hepatocytes. Dragani TA, Manenti G, Della Porta G. J Cancer Res Clin Oncol; 1987 Feb 10; 113(3):223-9. PubMed ID: 3584213 [Abstract] [Full Text] [Related]
10. Lack of promoting effect of clonazepam on the development of N-nitrosodiethylamine-initiated hepatocellular tumors in mice is correlated with its inability to inhibit cell-to-cell communication in mouse hepatocytes. Diwan BA, Lubet RA, Nims RW, Klaunig JE, Weghorst CM, Henneman JR, Ward JM, Rice JM. Carcinogenesis; 1989 Sep 10; 10(9):1719-24. PubMed ID: 2766464 [Abstract] [Full Text] [Related]
11. Effects of the oxazolidinedione anticonvulsants trimethadione and dimethadione and the barbiturate homolog 5,5-dimethylbarbituric acid on N-nitrosodiethylamine-initiated renal and hepatic carcinogenesis in the F344/NCr rat. Diwan BA, Nims RW, Henneman JR, Ward JM, Lubet RA, Rice JM. Arch Toxicol; 1992 Sep 10; 66(6):413-22. PubMed ID: 1444806 [Abstract] [Full Text] [Related]
12. Tumor-promoting and hepatocarcinogenic effects of 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene (TCPOBOP) in DBA/2NCr and C57BL/6NCr mice and an apparent promoting effect on nasal cavity tumors but not on hepatocellular tumors in F344/NCr rats initiated with N-nitrosodiethylamine. Diwan BA, Lubet RA, Ward JM, Hrabie JA, Rice JM. Carcinogenesis; 1992 Oct 10; 13(10):1893-901. PubMed ID: 1330346 [Abstract] [Full Text] [Related]
13. Dissimilar patterns of promotion by di(2-ethylhexyl)phthalate and phenobarbital of hepatocellular neoplasia initiated by diethylnitrosamine in B6C3F1 mice. Ward JM, Rice JM, Creasia D, Lynch P, Riggs C. Carcinogenesis; 1983 Aug 10; 4(8):1021-9. PubMed ID: 6872148 [Abstract] [Full Text] [Related]
14. Strain-dependent effects of phenobarbital on liver tumor promotion in inbred mice. Diwan BA, Rice JM, Ward JM. Prog Clin Biol Res; 1990 Aug 10; 331():69-83. PubMed ID: 2179966 [Abstract] [Full Text] [Related]
18. Apoptosis in stages of mouse hepatocarcinogenesis: failure to counterbalance cell proliferation and to account for strain differences in tumor susceptibility. Bursch W, Chabicovsky M, Wastl U, Grasl-Kraupp B, Bukowska K, Taper H, Schulte-Hermann R. Toxicol Sci; 2005 May 10; 85(1):515-29. PubMed ID: 15728704 [Abstract] [Full Text] [Related]
19. Further evidence of the tumor-suppressive effects of cadmium in the B6C3F1 mouse liver and lung: late stage vulnerability of tumors to cadmium and the role of metallothionein. Waalkes MP, Diwan BA, Weghorst CM, Ward JM, Rice JM, Cherian MG, Goyer RA. J Pharmacol Exp Ther; 1993 Sep 10; 266(3):1656-63. PubMed ID: 8371163 [Abstract] [Full Text] [Related]
20. Dose-response relationship of diethylnitrosamine-initiated tumors in neonatal balb/c mice: effect of phenobarbital promotion. Klaunig JE, Pereira MA, Ruch RJ, Weghorst CM. Toxicol Pathol; 1988 Sep 10; 16(3):381-5. PubMed ID: 3194660 [Abstract] [Full Text] [Related] Page: [Next] [New Search]